https://www.selleckchem.com/products/arn-509.html
Furthermore, digoxin was identified via Connectivity Map analysis (L100 for its capability to reverse gene signatures in patients with low DDX3X. Importantly, cancer cell proliferation and migration were decreased upon digoxin treatment in RCC cells. The results of this study indicate the significance of the DDX3Xlow/SPINK1high/metallothioneinhigh axis for predicting poor survival outcome in RCC patients and suggest digoxin as a precise and personalized compound for curing those patients with low DDX3X expression levels.Nowadays, food
Like
Comment
Share
